# XCF Global, Inc.: overview SAFX · Nasdaq · CIK 2019793 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/safx.md) · [Financials](/companies/safx/financials.md) · [Filings](/companies/safx/filings.md) · [Insiders](/companies/safx/insiders.md) Latest reported revenue: [$690.9k](/filings/0001493152-26-038610.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 17, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-038610). ## Last eight quarters | Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | [6.6](/filings/0001493152-26-038610.md) | [9.6](/filings/0001493152-25-023469.md) | [4.7 d](/filings/0001493152-26-014280.md) | [0.3](/filings/0001493152-26-023764.md) | [0.7](/filings/0001493152-26-038610.md) | | Gross margin | % | not reported | not reported | not reported | [(18.8%)](/filings/0001493152-26-038610.md) | [35.0%](/filings/0001493152-25-023469.md) | [(125.5%) d](/filings/0001493152-26-014280.md) | [(89.5%)](/filings/0001493152-26-023764.md) | [40.0%](/filings/0001493152-26-038610.md) | | Operating margin | % | not reported | not reported | not reported | [(522.8%)](/filings/0001493152-26-038610.md) | [(90.3%)](/filings/0001493152-25-023469.md) | [(405.0%) d](/filings/0001493152-26-014280.md) | [(2964.7%)](/filings/0001493152-26-023764.md) | [(833.2%)](/filings/0001493152-26-038610.md) | | Net margin | % | not reported | not reported | not reported | [1676.8%](/filings/0001493152-26-038610.md) | [(131.0%)](/filings/0001493152-25-023469.md) | [(347.4%) d](/filings/0001493152-26-014280.md) | [(5108.4%)](/filings/0001493152-26-038610.md) | [(2045.7%)](/filings/0001493152-26-038610.md) | | Diluted EPS | $ per share | not reported | not reported | [(0.05)](/filings/0001493152-26-023764.md) | [0.83](/filings/0001493152-26-038610.md) | [(0.08)](/filings/0001493152-25-023469.md) | not reported | [(0.07)](/filings/0001493152-26-023764.md) | [(0.04)](/filings/0001493152-26-038610.md) | | Free cash flow | $m | [(16.7) d](/filings/0001493152-25-023469.md) | [(8.6) d](/filings/0001493152-26-014280.md) | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | | Revenue | $m | [0.0](/filings/0001493152-26-014280.md) | [20.8](/filings/0001493152-26-014280.md) | | Gross margin | % | not reported | [(18.1%)](/filings/0001493152-26-014280.md) | | Operating margin | % | not reported | [(326.1%)](/filings/0001493152-26-014280.md) | | Net margin | % | not reported | [355.5%](/filings/0001493152-26-014280.md) | | Diluted EPS | $ per share | not reported | [0.52](/filings/0001493152-26-014280.md) | | Free cash flow | $m | [(39.8)](/filings/0001493152-26-014280.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/safx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.0m | 4,491,207 | | Added +3,100,072 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $330.4k | 747,648 | | Reduced −1,368,585 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $327.4k | 742,464 | | Reduced −708,145 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $297.3k | 673,450 | | Reduced −297,298 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $206.5k | 467,901 | | Reduced −1,950,630 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $175.0k | 396,511 | | Added +372,812 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $155.6k | 352,416 | | New +352,416 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $146.6k | 332,051 | | Reduced −542,411 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $138.6k | 313,961 | | Reduced −34,686 | | [J. Derek Lewis & Associates Inc.](/funds/2077884.md) | 2026-06-30 | $110.3k | 250,000 | | Added +5,060 | ## Recent filings [All 199 filings](/companies/safx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 16:05 ET | [DEF 14A](/filings/0001493152-26-048511.md) | Proxy statement, period 2026-10-26 | 0001493152-26-048511 | | 2026-10-23 | 16:30 ET | [8-K](/filings/0001213900-26-112143.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-112143 | | 2026-10-22 | 17:08 ET | [8-K](/filings/0001213900-26-111746.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-111746 | | 2026-10-16 | 17:13 ET | [SCHEDULE 13D/A](/filings/0002106572-26-000004.md) | Ownership report, active investor, amended | 0002106572-26-000004 | | 2026-10-06 | 16:15 ET | [8-K](/filings/0001213900-26-107213.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-107213 | | 2026-09-16 | 17:38 ET | [8-K](/filings/0001213900-26-100228.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-100228 | | 2026-09-15 | 16:22 ET | [SCHEDULE 13D](/filings/0002106590-26-000003.md) | Ownership report, active investor | 0002106590-26-000003 | | 2026-09-15 | 10:05 ET | [8-K](/filings/0001493152-26-042687.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-042687 | | 2026-09-14 | 16:16 ET | [8-K](/filings/0001213900-26-099716.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-099716 | | 2026-09-08 | 16:05 ET | [8-K](/filings/0001493152-26-041766.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041766 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-014280.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/eaceb464-df19-49cc-912e-b819f4cc7d13) ## About the filer - CIK: 2019793 - Tickers: SAFX - Exchange: Nasdaq - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:48 ET. No prices; not investment advice.